BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9541276)

  • 1. Effect of PP1D-1, a synthetic antiplatelet compound, on rabbit platelets.
    Liao CH; Ko FN; Kuo SC; Teng CM
    Jpn J Pharmacol; 1998 Feb; 76(2):141-8. PubMed ID: 9541276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet effect of demethyldiisoeugenol.
    Liao CH; Ko FN; Kuo YH; Teng CM
    Can J Physiol Pharmacol; 1996 Oct; 74(10):1111-6. PubMed ID: 9022830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets.
    Liao CH; Ko FN; Wu CL; Teng CM
    J Pharm Pharmacol; 2000 Mar; 52(3):353-9. PubMed ID: 10757426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets.
    Yu SM; Chen CC; Ko FN; Huang YL; Huang TF; Teng CM
    Biochem Pharmacol; 1992 Jan; 43(2):323-9. PubMed ID: 1310852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition on platelet activation by shikonin derivatives isolated from Arnebia euchroma.
    Ko FN; Lee YS; Kuo SC; Chang YS; Teng CM
    Biochim Biophys Acta; 1995 Sep; 1268(3):329-34. PubMed ID: 7548232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of p-chlorobiphenyl on the inhibition of platelet aggregation.
    Ko FN; Yeh LJ; Liang HC; Kuo SC; Teng CM
    J Pharm Pharmacol; 1996 Apr; 48(4):395-400. PubMed ID: 8794990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YC-1, a novel activator of platelet guanylate cyclase.
    Ko FN; Wu CC; Kuo SC; Lee FY; Teng CM
    Blood; 1994 Dec; 84(12):4226-33. PubMed ID: 7527671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of 3-[2-(cyclopropylamino)ethoxy]xanthone on platelet thromboxane formation.
    Chen WY; Ko FN; Lin CN; Teng CM
    Thromb Res; 1994 Jul; 75(1):81-90. PubMed ID: 8073410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory mechanisms of dantrolene on platelet aggregation.
    Chou TC; Li CY
    Thromb Res; 1999 Nov; 96(4):299-307. PubMed ID: 10593433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
    Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
    Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of collagen-induced platelet aggregation and adhesion by a pseudocyanide derivative of avicine isolated from Zanthoxylum integrifoliolum Merr.
    Ko FN; Hsiao G; Chen IS; Wu SJ; Teng CM
    Biochem Pharmacol; 1993 Oct; 46(7):1165-73. PubMed ID: 8216367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the antiplatelet effects of (2S)-5-methoxy-6-methylflavan-7-ol from Draconis Resina.
    Tsai WJ; Hsieh HT; Chen CC; Kuo YC; Chen CF
    Eur J Pharmacol; 1998 Apr; 346(1):103-10. PubMed ID: 9617759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb.
    Hsiao G; Ko FN; Jong TT; Teng CM
    Biol Pharm Bull; 1998 Jul; 21(7):688-92. PubMed ID: 9703250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
    Liao CH; Tzeng CC; Teng CM
    Eur J Pharmacol; 1998 May; 349(1):107-14. PubMed ID: 9669503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane A2 synthase inhibition and thromboxane A2 receptor blockade by 2-[(4-cyanophenyl)amino]-3-chloro-1,4-naphthalenedione (NQ-Y15) in rat platelets.
    Chang TS; Kim HM; Lee KS; Khil LY; Mar WC; Ryu CK; Moon CK
    Biochem Pharmacol; 1997 Jul; 54(2):259-68. PubMed ID: 9271330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cyclooxygenase activity and increase in platelet cyclic AMP by girinimbine, isolated from Murraya euchrestifolia.
    Ko FN; Lee YS; Wu TS; Teng CM
    Biochem Pharmacol; 1994 Jul; 48(2):353-60. PubMed ID: 8053931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of gingerol isolated from Zingiber officinale.
    Guh JH; Ko FN; Jong TT; Teng CM
    J Pharm Pharmacol; 1995 Apr; 47(4):329-32. PubMed ID: 7791032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet actions of 2-(4-[1-(2-chlorophenyl) piperazinyl]) methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one compound.
    Ding YA; Chou TC; Chern JW; Yen MH
    Thromb Res; 1995 Feb; 77(3):291-303. PubMed ID: 7740521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones.
    Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM
    Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.